Program Overview

The program is specifically designed to enhance current knowledge about the prevention, intervention and management of cardiovascular disease (CVD).  Presentations will provide Advanced Practice Nurses, Physician Assistants and Clinical Nurses with evidence-based approaches regarding treatment of advance heart failure, lipid management, cardio-oncology and mental health in patients with coronary artery disease (CAD). Lectures will include hemodynamics, LV assist device as therapy for complex valve disease, patients’  journey through heart transplantation, electrocardiogram (EKG) review, establishing genetic links in CAD, research reviews in diabetes mellitus (DM) and CVD.


Program Overview

Provide the Advanced Practice Nurses, Physician Assistants and Clinical Nurses the current knowledge in the prevention, intervention and management of CVD.

Learning Objectives

  • Discuss determinates of cardiac output and their relationships to each other
  • Discuss the pharmacologic strategies that improve cardiac output
  • Discuss the genetic  etiologies to consider when evaluating a patient with premature MI or CAD
  • Discuss the triggers for inflammation in atherosclerosis and the role of proprotein convertase
  • subtilisin/kexin type 9 (PCSK9) in decreasing vascular inflammation
  • Discuss the best practice management of patients with hyperlipidemia
  • Identify abnormal EKGs and  differentiate between life threatening and non-life threatening EKG
  • Discuss the relationship between CAD and diabetes mellitus
  • Discuss ways how healthcare professionals can stay healthy on the job
  • Discuss the mechanisms of cardio toxicity of several common chemotherapeutic agents
  • Identify the early signs or symptoms of cardiovascular disease in patients with cancer
  • Discuss the mental health indicators in the context of coronary heart disease (CHD)
  • Discuss the various therapies for advance heart failure
  • Discuss new strategies to prevent progression of valvular disease in patients with LVAD
  • Discuss the patients’ journey as patients move through the health care system through heart transplantation
  • Discuss different options for NPs who are considering DNP education


This education activity is pending approval by the American Association of Nurse Practitioners of up to 9.25 total contact hours with 4.5 accredited pharmacology content. This program was planned in accordance with AANP CE Standards and Policies.

Faculty Disclosure

It is the policy of The Icahn School of Medicine at The Mount Sinai Hospital to ensure objectivity, balance, independence, transparency, and scientific rigor in all sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship.


Presenters must also make a meaningful disclosure to the audience about their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.